Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Natraj Proteins
Join Channel
Consolidated Standalone

Natraj Proteins

₹51.8 2.5 | 5%

Market Cap ₹19 Cr.

Stock P/E -1.5

P/B 0.6

Current Price ₹51.8

Book Value ₹ 87.4

Face Value 10

52W High ₹68.8

Dividend Yield 0%

52W Low ₹ 38.5

Edit Ratio

Natraj Proteins Research see more...

Overview Inc. Year: 1990Industry: Edible Oil

Natraj Proteins Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Natraj Proteins Quarterly Results

#(Fig in Cr.) Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Jun 2023 Sep 2023 Dec 2023
Net Sales 28 35 49 32 22 30 41 41 36 78
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 29 35 49 32 22 30 41 41 36 78
Total Expenditure 19 26 48 37 22 31 39 46 41 79
Operating Profit 9 9 1 -4 1 -0 2 -5 -5 -1
Interest 0 0 0 1 1 0 0 1 1 1
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 9 9 0 -5 0 -1 1 -6 -6 -2
Provision for Tax 2 2 0 -1 0 0 0 0 0 0
Profit After Tax 7 7 0 -4 0 -1 1 -6 -6 -2
Adjustments -0 0 0 0 -0 0 0 0 0 -0
Profit After Adjustments 7 7 0 -4 0 -1 1 -6 -6 -2
Adjusted Earnings Per Share 17.8 17.9 0.8 -11.5 0.3 -1.5 2.5 -16.4 -15 -4.7

Natraj Proteins Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 319 364 302 201 258 194 191 154 146 145 144 196
Other Income 0 0 1 1 1 0 0 0 0 0 0 0
Total Income 320 364 303 201 259 195 191 154 146 145 144 196
Total Expenditure 299 348 296 202 254 188 185 150 143 131 141 205
Operating Profit 21 16 7 -1 5 7 6 5 3 14 3 -9
Interest 3 3 5 3 4 4 4 4 2 1 2 3
Depreciation 1 1 1 1 1 1 1 1 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 16 12 2 -5 0 2 1 0 1 13 1 -13
Provision for Tax 6 4 0 -0 0 0 0 -0 1 4 0 0
Profit After Tax 11 8 2 -5 0 2 1 0 0 9 1 -13
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 11 8 2 -5 0 2 1 0 0 9 1 -13
Adjusted Earnings Per Share 29 21.6 4.1 -14.2 0.6 4.3 3.1 0.9 1.1 25 1.9 -33.6

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -1% -2% -6% -8%
Operating Profit CAGR -79% -16% -16% -18%
PAT CAGR -89% 0% -13% -21%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 3% -0% 14% 4%
ROE Average 2% 9% 6% 8%
ROCE Average 4% 10% 9% 10%

Natraj Proteins Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 30 38 38 33 33 34 35 36 36 45 46
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 3 2 1 0 0 0 0 0 0 3 3
Other Non-Current Liabilities 2 2 1 1 1 1 1 1 1 1 1
Total Current Liabilities 44 57 56 37 32 71 36 34 31 26 40
Total Liabilities 79 99 95 71 65 106 73 71 68 76 89
Fixed Assets 9 9 6 5 4 4 4 3 3 4 4
Other Non-Current Assets 5 6 8 5 7 5 3 2 5 8 10
Total Current Assets 65 85 81 61 54 98 66 65 61 64 75
Total Assets 79 99 95 71 65 106 73 71 68 76 89

Natraj Proteins Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 1 16 10 20 6 3 0 4 2 0 5
Cash Flow from Operating Activities 30 -13 25 9 3 -37 30 2 9 6 3
Cash Flow from Investing Activities -2 -0 -2 4 -2 3 2 0 -0 -3 -3
Cash Flow from Financing Activities -12 7 -13 -27 -4 31 -28 -4 -10 2 -2
Net Cash Inflow / Outflow 16 -7 10 -14 -3 -3 4 -2 -2 5 -2
Closing Cash & Cash Equivalent 16 10 20 6 3 0 4 2 0 5 2

Natraj Proteins Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 28.98 21.64 4.05 -14.18 0.61 4.29 3.06 0.9 1.05 24.99 1.89
CEPS(Rs) 31.13 23.78 5.9 -12.21 2.3 5.88 4.8 2.59 2.12 26.04 3.03
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 79.41 101.05 101.14 86.88 87.24 91.56 94.43 95.11 96.26 121.32 123.38
Core EBITDA Margin(%) 6.31 4.18 1.97 -0.88 1.53 3.29 3.15 2.93 2.11 9.79 2.08
EBIT Margin(%) 6.18 4.1 2.06 -0.96 1.5 3.1 2.92 2.55 1.91 9.69 1.93
Pre Tax Margin(%) 5.16 3.35 0.56 -2.65 0.12 0.91 0.71 0.21 0.67 8.95 0.71
PAT Margin (%) 3.4 2.23 0.5 -2.64 0.09 0.82 0.6 0.22 0.27 6.47 0.49
Cash Profit Margin (%) 3.65 2.45 0.73 -2.28 0.33 1.13 0.94 0.63 0.54 6.74 0.79
ROA(%) 14.01 9.13 1.56 -6.39 0.33 1.87 1.28 0.47 0.56 12.98 0.86
ROE(%) 44.64 23.99 4.01 -15.09 0.7 4.79 3.29 0.95 1.1 22.97 1.54
ROCE(%) 28.13 18.65 7.33 -2.91 7.49 8.65 7.19 5.93 4.47 21.43 3.63
Receivable days 5.59 6.3 12.61 17.4 11.77 23.71 32.7 44.63 40.63 40.26 37.52
Inventory Days 55.35 53.01 66.66 80.45 56.82 109.36 117.24 98.66 108.95 107.21 122
Payable days 1.5 3.1 10.38 22.81 17.8 27.32 20.16 7.7 12.92 12.55 10.33
PER(x) 0.95 1.39 10.38 0 52.84 6.85 8.79 24.44 26.38 4.21 20.46
Price/Book(x) 0.35 0.3 0.42 0.3 0.37 0.32 0.28 0.23 0.29 0.87 0.31
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.11 0.14 0.13 0.11 0.11 0.33 0.19 0.24 0.22 0.43 0.32
EV/Core EBITDA(x) 1.72 3.34 5.61 -19.28 6.07 9.73 5.93 8.06 10.13 4.29 14.31
Net Sales Growth(%) 44.84 13.88 -17.03 -33.52 28.86 -24.78 -1.9 -19.18 -5.13 -1.03 -0.77
EBIT Growth(%) 111.48 -24.5 -58.32 -131.13 300.56 56.22 -8.18 -29.24 -29.14 403.09 -80.24
PAT Growth(%) 206.69 -25.31 -81.28 -450.11 104.28 606.37 -28.59 -70.44 16.12 2279.21 -92.44
EPS Growth(%) 206.69 -25.31 -81.28 -450.11 104.28 606.41 -28.59 -70.44 16.12 2279.16 -92.44
Debt/Equity(x) 1.39 1.34 1.13 0.6 0.58 1.58 0.87 0.87 0.61 0.6 0.73
Current Ratio(x) 1.48 1.48 1.46 1.65 1.71 1.38 1.84 1.91 1.94 2.42 1.89
Quick Ratio(x) 0.58 0.32 0.67 0.44 0.57 0.23 0.7 0.68 0.51 0.91 0.48
Interest Cover(x) 6.07 5.5 1.37 -0.57 1.09 1.42 1.32 1.09 1.54 13.08 1.58
Total Debt/Mcap(x) 4 4.52 2.72 1.98 1.57 4.93 3.06 3.73 2.14 0.69 2.33

Natraj Proteins Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 48.91 48.91 48.27 46.87 45.51 44.91 44.88 44.38 43.8 43.68
FII 0 0 0 0 0 0 0 0 0 0
DII 1.93 1.93 1.93 1.93 1.93 1.93 1.93 1.93 1.93 1.93
Public 49.15 49.15 49.8 51.2 52.56 53.16 53.19 53.69 54.27 54.39
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Stock is trading at 0.6 times its book value
  • Debtor days have improved from 12.55 to 10.33days.

Cons

  • Promoter holding is low: 43.68%.
  • Company has a low return on equity of 9% over the last 3 years.
  • The company has delivered a poor profit growth of -12% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Natraj Proteins News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!